Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children With CF

NCT00676169 is registered in ClinicalTrials.gov with CF Therapeutics Development Network Coordinating Center as lead sponsor.

NCT NCT00676169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00676169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Assessment of Risk Factors For and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children With CF
Lead sponsor
CF Therapeutics Development Network Coordinating Center
Phase
Observational
Overall status
Completed
Start date
October 31, 2004
Completion date
December 31, 2018
Enrollment
1,248 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis